Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CFO Appointed at BioConvergence | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

CFO Appointed at BioConvergence

Eddy to oversee finance, HR, IT

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Kathy Eddy has been named chief financial officer at BioConvergence. She will oversee the finance, HR and IT departments. The company noted that this appointment reflects the continued growth of BioConvergence and the increasing scope and complexity of the financial, personnel, and technology requirements within the pharmaceutical industry.

“We’re fortunate to have someone with Kathy’s experience, expertise and vision to join our team,” said Alisa Wright, BioConvergence’s chief executive officer. “She will work closely with our leadership team and business groups in aligning and expanding our capabilities to better serve our clients.”

Ms. Eddy has more than 25 years of experience in finance with a concentration in taxation. In her most recent position at Lilly as director of Federal Tax and Global Tax Process, her responsibilities included Sarbanes Oxley compliance, mergers and acquisitions, income tax compliance, tax accounting and tax issue resolution. She also provided oversight for the management and planning of global tax processes including the tax research library and tax software.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters